KILITCH DRUGS (INDIA)
Back to Cashflow Statement
|
KILITCH DRUGS (INDIA) Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹5.97 Cr | ₹-9.16 Cr | ₹-0.88 Cr | ₹9.78 Cr | ₹-2.44 Cr |
What is the latest Net Cash Inflow / Outflow ratio of KILITCH DRUGS (INDIA) ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹5.97 Cr |
| Mar2025 | ₹-9.16 Cr |
| Mar2024 | ₹-0.88 Cr |
| Mar2023 | ₹9.78 Cr |
| Mar2022 | ₹-2.44 Cr |
How is Net Cash Inflow / Outflow of KILITCH DRUGS (INDIA) Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹5.97 Cr | Positive | |
| Mar2025 | ₹-9.16 Cr | Negative | |
| Mar2024 | ₹-0.88 Cr | Negative | |
| Mar2023 | ₹9.78 Cr | Positive | |
| Mar2022 | ₹-2.44 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹599.9 Cr | -0.3% | -8.9% | -6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,791.0 Cr | 1.7% | -1.4% | 21.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,081.0 Cr | 2% | 10.3% | 49.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,351.0 Cr | -0.4% | -0.5% | 38.6% | Stock Analytics | |
| CIPLA | ₹114,163.0 Cr | -0.5% | -2.5% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.3 Cr | -1.2% | 0% | -7.1% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | -0.3% |
-8.9% |
-6% |
| SENSEX | -1.2% |
-2.6% |
-5.2% |
You may also like the below Video Courses